Convergence of metadynamics simulations. (A) Comparison of free energy surfaces (FES) produced at different timepoints (1,000, 2,000, 3,000 and 4,000 ns) for neutral flecainide. (B) The number of FES grid points in the pore and fenestration region sampled over the course of metadynamics simulations for all drugs.